If century-old Abbott Building at 1045 Sansome Street sells at asking price, it would trade at 57% below its 2020 market value.

In a report released today, Kate McShane from Goldman Sachs maintained a Hold rating on Williams-Sonoma (WSM – Research Report), with a price

Critics say annexation could allow developer of master-planned city to bypass approval by Solano County voters.

Following 60% year-over-year growth in the last quarter, Databricks continues to bring in major investors to support its ongoing global expansion.

Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing back after four years of comparatively more scrutiny.

KittyHawk focuses on investments across artificial intelligence, longevity, advanced materials, MedTech, FinTech, cybersecurity, robotics, aerospace, SaaS, climate, and more. Through its partnership with NPM,

Suisun City, which spans about four square miles south of Fairfield, voted last week to explore annexing unincorporated county land outside the city’s border which includes a large part of the nearly 60,000 acres that were acquired by California Forever investors aiming to build a new walkable, mixed-use city from scratch.

Databricks attracts Meta investment as JPMorgan Chase leads consortium in combined equity and debt round, signalling shift in AI infrastructure funding

US-based data and AI company Databricks has raised $15.2bn through a combination of debt and equity funding. The company has announced the completion of its $10bn Series J funding round, which brings its valuation to $62bn.

H e brandished a chainsaw at campaign rallies, to signify his eagerness to clear-cut the thickets of bureaucracy and regulation impeding the economy’s progress. Perhaps more strikingly, he has actually lived up to this act.

SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases,

Alphabet’s Google, already facing an unprecedented regulatory onslaught, is looking to shape public perception and policies on artificial intelligence ahead of a global wave of AI regulation. A key priority,